Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
How a Novo Nordisk Foundation-funded project sparked ultra-processed food fight
Yahoo/Reuters
Thu, 03/13/25 - 11:38 am
Novo Nordisk
Novo Nordisk Foundation
Novo Nordisk's Ozempic successor disappointed Wall Street again
Yahoo Finance
Mon, 03/10/25 - 11:13 am
Novo Nordisk
obesity
CagriSema
clinical trials
Novo Nordisk welcomes patients to the Ozempic Era
Medical Marketing and Media
Mon, 03/10/25 - 09:29 am
Novo Nordisk
Ozempic
Wegovy
pharma marketing
DTC advertising
Novo Nordisk to explore how GLP-1 drugs can help patients with addiction
Pharma Live
Thu, 03/6/25 - 10:17 pm
Novo Nordisk
GLP-1 agonist
addiction
'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen
Yahoo Finance
Thu, 03/6/25 - 11:39 am
Novo Nordisk
trade
tariffs
Pharma CEOs
Lars Jørgensen
In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in
Fierce Pharma
Thu, 03/6/25 - 11:02 am
Novo Nordisk
drug compounding
legal
Texas
obesity
FDA
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
Fierce Pharma
Wed, 03/5/25 - 11:59 am
Novo Nordisk
DTC
Wegovy
Eli Lilly
weight loss
drug compounding
Novo bets up to $354M per target on Gensaic’s tissue-selective delivery tech
Fierce Biotech
Mon, 03/3/25 - 10:52 am
Novo Nordisk
Gensaic
artificial intelligence
drug discovery
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Fierce Pharma
Mon, 02/24/25 - 11:09 am
earnings
Big Pharma
Eli Lilly
Novo Nordisk
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
CNBC
Fri, 02/21/25 - 10:48 am
FDA
drug shortages
Novo Nordisk
Ozempic
Wegovy
Insurers push back on Medicare and Medicaid coverage for GLP-1s
Axios
Thu, 02/20/25 - 11:37 am
insurers
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Mounjaro
Wegovy
Novo seeks $830M in fraud case against Singaporean biotech over kidney drug
BioSpace
Tue, 02/18/25 - 11:13 am
legal
Novo Nordisk
hypertension
kidney disease
fraud
KBP Biosciences
First biosimilar fast-acting insulin reaches US market
Pharmaphorum
Tue, 02/18/25 - 09:47 am
Sanofi
Novo Nordisk
Novolog
insulin
diabetes
biosimilars
Merilog
Ozempic Shows Some Promise for Alcohol Use Disorder
US News and World Report
Wed, 02/12/25 - 09:26 pm
Novo Nordisk
Ozempic
alcohol-use disorder
Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Clinical Trials Arena
Fri, 02/7/25 - 11:42 am
Novo Nordisk
CagriSema
obesity
clinical trials
Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect
Fierce Biotech
Fri, 02/7/25 - 11:02 am
Novo Nordisk
hemophilia A
Mim8
pediatric
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Yahoo/Reuters
Thu, 02/6/25 - 11:40 am
Novo Nordisk
tariffs
Europe
Donald Trump
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
CNBC
Wed, 02/5/25 - 10:42 pm
Novo Nordisk
Wegovy
earnings
Novo flunks kidney disease trial, again linking obesity prospect to neuropsychiatric side effects
Fierce Biotech
Wed, 02/5/25 - 11:21 am
Novo Nordisk
clinical trials
diabetic kidney disease
Monlunabant
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »